News

The phase III trial, being conducted in Europe and Canada, is investigating the safety and efficacy of TH-070 in patients with benign prostatic hyperplasia (BPH). Approximately 500 patients

Based upon previous results from a phase I study in which three out of three advanced melanoma patients with solid tumors had complete responses to TNFerade plus radiation

Vertex has earned a $10 million milestone payment from Merck & Co. as a result of this step forward in the drug’s development. The companies entered a global

Centocor is seeking approval for the treatment of moderately to severely active pediatric Crohn’s disease in patients who have had an inadequate response to conventional therapies. Currently, there

In the ongoing phase II colorectal cancer trial, patients with colon cancer, which has spread despite treatment with approved therapies, are receiving Davanat plus 5-fluorouracil in monthly cycles

The study used a combination of Evoltra (clofarabine) with the traditional chemotherapy agent daunorubicin. Results showed an overall response had been achieved in 92% of patients over 60

Jack Hammond, USW District 12 international representative, said the National Labor Relations Board (NLRB) had already issued a complaint against Medco for its illegal interference with employees’ solidarity

Post-marketing study commitments (PMCs), also called phase IV commitments, are studies conducted after FDA has approved a product for marketing that a sponsor is required, or has agreed,

Super Fat Burning and LiDa Daidaihua Slimming Capsules are not authorized for sale in Canada. The two products have so far not been found on the Canadian market,